Match Document Document Title
US20140072624 UNIT DOSE FORM FOR ORAL ADMINISTRATION  
Formulations and unit dose forms of TH-302 and other hypoxia activated prodrugs suitable for oral administration are useful for treating cancer.
US20110300207 METHOD OF TREATING POST-SURGICAL ACUTE PAIN  
A method is provided for treating pain in patients recovering from post-surgical trauma by administering between about 13 to about 30 mg of diclofenac potassium in a liquid dispersible formulation...
US20150196495 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit  
A solid dosage form designed to facilitate rapid and reliable oral, esophageal and GI transit has a surface area of the contact patch, i.e., the area of contact between the dosage form and the...
US20110311617 ORAL VACCINE  
The present invention provides an oral vaccine against a bacterial infectious disease (e.g., typhoid fever, cholera, or dysentery). The oral vaccine of the present invention is a capsule...
US20120308652 ORAL FORM OF ADMINISTRATION COMPRISING ENTECAVIR  
The invention relates to pharmaceutical formulations, preferably in the form of an oral dosage form, for the treatment of chronic hepatitis-B virus infections, containing micronised Entecavir, and...
US20110150986 QUININE FORMULATIONS, METHOD OF MAKING, AND METHO OF USE THEREOF  
Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or...
US20130095177 METHOD OF PREPARING AN ORAL DOSAGE FORM COMPRISING FINGOLIMOD  
The present invention relates to a method of preparing an intermediate containing fingolimod, a method of preparing granules containing fingolimod, a method of preparing an oral dosage form...
US20130149377 CUSTOM-PILL COMPOUNDING SYSTEM WITH FILLER-FREE CAPABILITY  
A system and associated aspects thereof are disclosed regarding custom-compounding of drug products such as pills and polypills for particular patients, herein involving adaptations of...
US20110287085 LIPOSOMAL CURCUMIN FOR TREATMENT OF CANCER  
The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of...
US20130045274 BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS  
This document discusses, among other things, receiving a plurality of donor fecal samples from a plurality of donors and storing and indexing each respective donor fecal samples using at least one...
US20140322311 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM  
The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one...
US20140170214 SUPRAMOLECULAR CAPSULES  
Provided is a capsule having a shell of material that is a supramolecular cross-linked network. The network is formed from a host-guest complexation of cucurbituril (the host) and one or more...
US20140065210 PROTEIN STABILIZED PROBIOTICS AND PERSONAL CARE PRODUCTS  
The present invention relates to a personal care product comprising a protein matrix wherein said protein matrix comprises at least one protein, at least one probiotic and a carrier fluid. The...
US20150064244 KONJAC FORMULATION AND METHOD FOR PREPARING THE SAME  
A konjac formulation in the form of a capsule, including between 85 and 95 parts by weight of konjac gum, between 5 and 10 parts by weight of black rice, between 0.5 and 2 parts by weight of...
US20140328906 Methods of Treating Impaired Glucose Metabolism via Administration of Algal Biomass  
The invention is directed to methods of using Chlorella protothecoides microalgal biomass in the treatment of individuals having impaired glucose metabolism. In some cases, the patient has...
US20120183605 QUININE FORMULATIONS, METHOD OF MAKING, AND METHOD OF USE THEREOF  
Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or...
US20110165233 STABILITY ADDITIVES FOR DRY DHA DOSAGE FORMS  
The use of additives to stabilize DHA when compressed into tablets, or filled as a powder into capsules, for oral administration.
US20140010868 KRILL OIL AND CAROTENOID COMPOSITION, ASSOCIATED METHOD AND DELIVERY SYSTEM  
A medicine delivery system includes an inner capsule containing carotenoids and an outer capsule in which the inner capsule is contained within the outer capsule and the outer capsule containing a...
US20130251789 TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS  
Disclosed is an oral dosage form comprising: (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
US20140072623 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20130224289 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20120148671 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20140341983 SMART™ SOLID ORAL DOSAGE FORMS  
Solid Oral Dosage Forms (SODFs) comprising Self Monitoring and Reporting Therapeutics (SMART™) adherence technology are provided which require no or minimal modification of clinical trial...
US20140023702 METHOD OF TREATING RETINITIS PIGMENTOSA  
Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the...
US20110033528 STABILIZED PICOPLATIN ORAL DOSAGE FORM  
The invention provides an oral dosage form for the anti-cancer drug picoplatin comprising a core and a coating, the dosage form being free of redox-active metal salts. The core of the tablet is a...
US20140370084 ESTRADIOL FORMULATIONS AND THERAPIES  
Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized...
US20130089592 METHOD OF PRODUCING A HYDROGEL  
The invention provides a method of enzymatically modifying xylan by selectively removing glucuronic acid and/or arabinose side chains from the xylan with a-D-glucuronidase and/or...
US20110189091 COLON LAVAGE SYSTEM  
The present invention provides compositions, systems, kits, and methods for preparation prior to a colonoscopy or other gastrointestinal procedure. In particular, the present invention provides a...
US20140294947 TAMPER RESISTANT IMMEDIATE RELEASE FORMULATIONS  
Disclosed in certain embodiments is an oral dosage form comprising a plurality of particles, each particle comprising (i) a core comprising a gelling agent; (ii) an optional barrier layer...
US20110081412 ORALLY DISINTEGRABLE TABLETS  
An orally disintegrable tablet, of the present invention, which comprises (i) fine granules having an average particle diameter of 400 μm or less, which fine granules comprise a composition coated...
US20150017237 DOSAGE FORM COMPRISING LOPINAVIR AND RITONAVIR  
The present invention relates to an oral dosage form comprising crystalline lopinavir and crystalline ritonavir. The invention further relates to methods of preparing said oral dosage forms...
US20150044281 METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND OTHER DEMYELINATING DISORDERS  
This invention provides compositions and methods for preventing multiple sclerosis or other demyelinating disorders, inhibiting multiple sclerosis or other demyelinating disorders, or prolonging...
US20110144006 PROTEIN COMPOSITION  
The invention relates to a protein composition which upon ingestion by a healthy person with a normal fasting insulin level between 3.0-8.0 μU/L increases the insulin level to at most 20.0 μU/L....
US20150064241 Delivery of Functionalized Particles  
A device includes a capsule sized to pass through a lumen of a gastrointestinal tract, a plurality of functionalized particles disposed within the capsule, one or more tissue penetrating members...
US20120107394 IMMUNO-COMPATIBLE HYDROGEL SYSTEM  
An immuno-compatible hydrogel system is provided that is resistant to protein binding. The hydrogel system is prepared by contacting a hydrogel solution with a cross-linking agent to form a gel,...
US20150258032 Compositions of Antioxidants and Oil for an antioxidant paste or supplement or liquid or frozen product  
The invention provides ways to make high antioxidant highly nutritious natural powders appealing and palatable in additives or spreads or drinks or snacks or frozen products or more bio-available...
US20120237597 METHOD FOR TREATING PSORIASIS  
A method for treating psoriasis in a subject suffering from psoriasis comprising orally administering to the subject a pharmaceutically effective amount of crude Dunaliella powder.
US20130064884 COMPOSITION AND METHOD FOR TREATING KETOSIS IN COWS  
A method for prophylactic treatment of ketosis in a calving cow, the method including orally administering to the cow within a time period of about 12 hours after calving an effective dose of from...
US20120052117 Soft capsule of butylphthalide and a process for preparing the same  
The present invention discloses a novel soft capsule of butylphthalide and a process for preparing the same. The soft capsule of butylphthalide is composed of a capsule wall material and a...
US20150071993 Compositions and Methods for Improving Sleep Using A Nutraceutical Formulation  
Provided are supplemental compositions for a nutraceutical formulation and methods for administering the same to a user for inducing or maintaining sleep as well as for alleviating pain to improve...
US20150093436 MODIFIED RELEASE DOSAGE FORMS OF SKELETAL MUSCLE RELAXANTS  
A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion...
US20140079777 DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS  
Dry powder vancomycin compositions and methods for administering and preparing such compositions are provided.
US20150224058 FORMULATIONS OF FLIBANSERIN  
The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin.
US20120321704 Compound sea Cucumber Product, Preparation Method, and Dosage Forms Thereof  
A compound sea cucumber product, preparation method thereof and dosage forms thereof are disclosed. A fresh sea cucumber is cut open, the viscus thereof is taken out, and they are well-cleaned...
US20150209360 ORAL CAFFEINE DELIVERY COMPOSITION  
Apparatuses, systems, and methods are disclosed for an oral caffeine delivery composition. A liquid mixture comprises granulated caffeine crystals. A liquid mixture comprises an early-onset...
US20120282330 CHINESE HERBAL COMPOSITION FOR THE TREATMENT OF MACULAR DEGENERATION AND THE PROCESS FOR MANUFACTURING THE SAME  
The present invention provides a Chinese herb composition for the treatment of macular degeneration and its preparation method. The composition comprises Salviae miltiorrhizae, Chuanxiong rhizoma,...
US20140112985 METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION  
This invention relates to prophylactic and/or therapeutic application of microorganism species that are, for example, administered orally as delayed release formulation designed to release its...
US20130142870 NERAMEXANE MULTIPLE UNIT DOSAGE FORM  
Unit comprising neramexane, a pharmaceutically acceptable salt, solvate, conjugate, prodrug, polymorphic form, isomer, or derivative thereof; and a release-controlling excipient; wherein said unit...
US20120321703 CAPSULE FOR ORAL PET MEDICINE  
A capsule for the administration of pet medicine is described. The capsule comprises a main hollow body containing a liquid ingredient and having the configuration of a pet treat for receiving and...
US20140120161 VECTOR FOR ORAL ADMINISTRATION  
A vector for the oral administration of at least one pharmacologically active substance enabling the active substance to move from the intestinal lumen to the blood, optionally via interstitial...